Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002). - Yang DL; Qin C; Peng N; Liu SP; Yu YQ; Nong JL; Zeng FJ; Su Z; Yang YY; Yang FQ; Li MJ; Wu MS; et al. (Communications medicine, 2026)